Mumbai, April 2022 – Specialty chemicals company LANXESS will globally implement a variable pricing surcharge for its Lewatit ion exchange resins and Bayoxide iron oxide adsorbers which will be applied with immediate effect. The existing fixed surcharge will be adjusted based on the most relevant input costs on a monthly basis. In April/May 2022 Customers will be contacted individually.
This step became necessary since the already tense cost situation has worsened even further due to the war in the Ukraine. The markets worldwide are experiencing an unprecedented volatility and prices for energy, raw materials and transportation increased at unexpected and unpredictable magnitudes.
The LANXESS Liquid Purification Technologies business unit is one of the world’s leading global solution providers for water treatment and liquid purification. Ion exchange resins and iron oxide adsorbers are used in numerous industries and applications to purify water and other liquid media effectively.
More Stories
CARE Hospitals Wins Multiple National Awards for Quality and Patient-Centric Care at AHPI Global Conclave 2026
Hyderabad, 25 January 2026: The Association of Healthcare Providers India (AHPI) organised the two-day AHPI Global Conclave 2026, themed “Empowering...
Chevella MP Konda Vishweshwar Reddy inaugurated Leela Specialty Clinics
Hyderabad, 25th January 2026: Leela Speciality Clinics was inaugurated today at Narsingi registration office road by Shri Konda Vishweshwar Reddy,...
Fortis Hospital Anandapur Hosts Kolkata’s First-Ever IV Nurses Walkathon
Kolkata, Jan 25: On the occasion of International IV Nurses Day, Fortis Hospital, Anandapur, in collaboration with the Bengal Chapter...
Manipal Hospital Yeshwanthpur Expands Advanced Pediatric Specialties with Two Key Clinical Appointments
Bengaluru: Manipal Hospital Yeshwanthpur, Bengaluru, has further enhanced its pediatric care services with the addition of two experienced consultants in highly specialised domains—paediatric neurology and paediatric endocrinology....
Zydus launches the world’s first biosimilar of Nivolumab, ‘Tishtha™’, in India to treat multiple cancers
Bengaluru, Jan 22: Zydus Lifesciences Limited an innovation-led life-sciences company with an international presence has launched the world’s first biosimilar...
Kenyan Woman Finds New Life After Kidney Transplant at AINU Hitec City
Hyderabad, Jan 22: Mrs. Fathumo Mohamud Dubow, a 55-year-old woman from Kenya, suffering from polycystic kidney disease and end-stage renal failure,...
